Last updated on January 2019

Influence of Central Obesity on the Esophageal Epithelial Barrier


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Gastroesophageal Reflux
  • Age: Between 18 - 85 Years
  • Gender: Male or Female

Inclusion Criteria:

Participants who are undergoing clinically indicated upper endoscopy with Bravo ambulatory pH capsule (off reflux medications for 7 days), in the Esophageal Clinic at Mayo Clinic.

Exclusion Criteria:

  1. Pre-existing or suspected Barrett's Esophagus (> 1cm of columnar mucosa in esophagus on endoscopy
  2. Oral anticoagulation precluding endoscopic biopsies
  3. Patients with known hypersensitivity to fluorescein sodium.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.